RecruitingPhase 2NCT05414409

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

The Gut Microbiome in Lean and Overweight Youth With Type 1 Diabetes and Novel Mechanism of Action of Metformin


Sponsor

Heba M. Ismail

Enrollment

114 participants

Start Date

Sep 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for complications. The proposed study is relevant to public health because it helps us understand the role of the gut microbiome in disease pathophysiology in T1D youth with overweight and obesity as well as potential mechanisms to modify disease.


Eligibility

Min Age: 11 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring how the gut microbiome (the community of bacteria living in the digestive system) affects blood sugar control in young people with Type 1 Diabetes, and how the medication metformin might play a role. Researchers hope to better understand the connection between gut health and diabetes management in teenagers. **You may be eligible if...** - You are between 11 and 18 years old - You have Type 1 Diabetes - You are either overweight/obese OR lean/normal weight **You may NOT be eligible if...** - You have a rare genetic form of diabetes or Type 2 Diabetes - You have had an infection or taken antibiotics in the past month - You have a weakened immune system or have taken steroids or immune-suppressing medications in the past 6 months - You have a chronic digestive condition - You are pregnant or planning to become pregnant - You use tobacco, cannabis, or recreational drugs - You take probiotics or have had weight loss surgery Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMetformin

Metformin is an oral medication that improves insulin sensitivity.


Locations(1)

Indiana University School of Medicine

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05414409


Related Trials